Canadian Attorney Files Xarelto Class Action Alleging Uncontrollable Bleeding Risk
A class action Xarelto lawsuit has been filed in Canada by several individuals who allegedly sustained uncontrollable bleeding episodes due to the blood thinner, and will soon be followed by another, the Calgary Sun reports.
A report on February 13th indicates that the first case in the already-filed action is represented by a Calgary woman who nearly suffered cardiac arrest in September 2012 after she developed internal bleeding. Her Xarelto lawyer asserts in the claim that “The health care professionals who were treating Betty for this hemorrhaging had considerable difficulty in stopping her bleeding.”
The Toronto attorney estimates that the damage award in this case could be millions to the plaintiff, before adding that a similar action will soon be filed in Ontario, where a woman allegedly bled to death after taking the anticoagulant. Also included in her Xarelto lawsuit are the findings of a German report that linked 130 deaths to the medication in 2012 and 2013, and a statistic that 1,100 adverse event reports alleging uncontrollable bleeding and other complications have been logged in Health Canada’s database. “A dozen of those adverse events registered with Health Canada indicated that death had resulted from Xarelto,” the attorney noted.
Xarelto Bleeding Alleged in Hundreds of Federal Cases
As the litigation involving this anticoagulant continues to build in Canada, more lawsuits are being filed in the U.S. by individuals who allege life-threatening episodes of internal bleeding, as well as pulmonary embolism, deep vein thrombosis and other complications that may result in death. In December 2014, a federal panel issued a Transfer Order that moved all similar cases involving Xarelto to the U.S. District Court, Eastern District of Louisiana. There, a federal multidistrict litigation (MDL) has been established for cases that accuse Johnson & Johnson’s Janssen unit and Bayer Healthcare, who jointly market the anticoagulant, of failing to warn about the severity of its side effects. There is no available reversal agent to stop Xarelto internal bleeding once it begins, plaintiffs allege, meaning that they could result in a patient bleeding to death. As of February 2015, at least 220 lawsuits over the blood thinner had been filed in the federal proceeding.
Call a Xarelto Attorney Today.
Xarelto attorneys are standing by to answer any questions you have regarding the legal process of filing a claim. Call us now at (877) 779-1414.